Liu, Z., Cheng, X., Zhang, C. et al. Observation on effect of Shenmai injection in treating patients of congestive heart failurein treating patients of congestive heart failure., CJIM 6, 119–121 (2000). https://doi.org/10.1007/BF02970581
Liu Zhihong, Cheng Xiansheng, Zhang Chaoyang, et al. Observation on effect of Shenmai injection in treating patients of congestive heart failurein treating patients of congestive heart failure. [J]. Chinese Journal of Integrative Medicine 6(2):119-121(2000)
Liu, Z., Cheng, X., Zhang, C. et al. Observation on effect of Shenmai injection in treating patients of congestive heart failurein treating patients of congestive heart failure., CJIM 6, 119–121 (2000). https://doi.org/10.1007/BF02970581DOI:
Liu Zhihong, Cheng Xiansheng, Zhang Chaoyang, et al. Observation on effect of Shenmai injection in treating patients of congestive heart failurein treating patients of congestive heart failure. [J]. Chinese Journal of Integrative Medicine 6(2):119-121(2000) DOI: 10.1007/BF02970581.
Observation on effect of Shenmai injection in treating patients of congestive heart failurein treating patients of congestive heart failure
摘要
Objective: To observe the clinical therapeutic effect of Shenmai Injection (SMI) in treating patients of congestive heart failure.Methods: Effect of 16 cases treated with either SMI or potassium magnesium aspartate was observed by randomized crossover method and compared.Results: By using SMI for 2 weeks
the patients’ left ventricular ejective fraction (LVEF) was increased from 29.5 ± 9.0 to 36.6 ± 10.2 (P < 0.05)
the heart function of 68.75% patients was improved
no side effect or toxicity was observed. Potassium magnesium aspartate improved the heart function in 37. 50% patients only but showed no effect on LVEF.Conclusion: SMI is an effective and safe drug in treating patients with congestive heart failure.
Abstract
Objective: To observe the clinical therapeutic effect of Shenmai Injection (SMI) in treating patients of congestive heart failure.Methods: Effect of 16 cases treated with either SMI or potassium magnesium aspartate was observed by randomized crossover method and compared.Results: By using SMI for 2 weeks
the patients’ left ventricular ejective fraction (LVEF) was increased from 29.5 ± 9.0 to 36.6 ± 10.2 (P < 0.05)
the heart function of 68.75% patients was improved
no side effect or toxicity was observed. Potassium magnesium aspartate improved the heart function in 37. 50% patients only but showed no effect on LVEF.Conclusion: SMI is an effective and safe drug in treating patients with congestive heart failure.
关键词
congestive heart failureShenmai injectionheart function
Keywords
congestive heart failureShenmai injectionheart function
references
Philip A. Thrombolytic therapy, Where are we now? Medical Progress SEA 1995;22(9):9–12.
Li Xinhua. Shenmai Injection in treating 30 cases of protracted shock. J of Chengdu College of TCM 1988; 12(2): 19–20.
Xu Yali, Dong Jianying, LI Ziyu. Experimental study on cardiotonic effect of Shenmai Injection. Jianxi Medical J 1993;28(6): 323–326.
Liu Guiming, Wang Shuyun. Shenmai Injection in treating 36 cases of chronic congestive heart failure. Hunan J of TCM 1994;10(5):37–38.
Benack RT. Etiology of congestive heart failure in clinical medicine. Ann of the New York Acad. of Sciences 1969; 156:594–596.
Qin Lamei, Yang Jinduo, Liao Jiazhen. Further observation on effect of Shenmaisan on ATPase activity in my-ocardial cells of rats. Chinese J of Critical Care Medicine 1983;9(2):326–328.
Dong Quanzhen, Chen Keji. Commentary on studies of treating acute myocardial infarction with Shenmaisan. Chinese J of Integrated Traditional Chinese and Western Medicine 1983;3(1): 52.
Jin Xianqiao, Duan Shengfu, Niu Ruji, et al. Effect of Shenmai Injection and its ingredients on blood gas and hemorheology in rats with chronic anoxia. Chinese J of Integrated Traditional Chinese and Western Medicine 1995; 15(3):162–164.